Jump to content
 







Main menu
   


Navigation  



Main page
Contents
Current events
Random article
About Wikipedia
Contact us
Donate
 




Contribute  



Help
Learn to edit
Community portal
Recent changes
Upload file
 








Search  

































Create account

Log in
 









Create account
 Log in
 




Pages for logged out editors learn more  



Contributions
Talk
 



















Contents

   



(Top)
 


1 References  














Uramustine






العربية
Français
Italiano

Română
Русский
Српски / srpski
Srpskohrvatski / српскохрватски
Tiếng Vit
 

Edit links
 









Article
Talk
 

















Read
Edit
View history
 








Tools
   


Actions  



Read
Edit
View history
 




General  



What links here
Related changes
Upload file
Special pages
Permanent link
Page information
Cite this page
Get shortened URL
Download QR code
Wikidata item
 




Print/export  



Download as PDF
Printable version
 
















Appearance
   

 






From Wikipedia, the free encyclopedia
 


Uramustine
Clinical data
ATC code
Pharmacokinetic data
Protein binding5%
ExcretionRenal
Identifiers
  • 5-[bis(2-Chloroethyl)amino]-1H-pyrimidine-2,4-dione

CAS Number
PubChem CID
IUPHAR/BPS
DrugBank
ChemSpider
UNII
KEGG
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.000.574 Edit this at Wikidata
Chemical and physical data
FormulaC8H11Cl2N3O2
Molar mass252.10 g·mol−1
3D model (JSmol)
  • O=C1C(\N(CCCl)CCCl)=C/NC(=O)N1

  • InChI=1S/C8H11Cl2N3O2/c9-1-3-13(4-2-10)6-5-11-8(15)12-7(6)14/h5H,1-4H2,(H2,11,12,14,15) ☒N

  • Key:IDPUKCWIGUEADI-UHFFFAOYSA-N ☒N

 ☒NcheckY (what is this?)  (verify)

Uramustine (INN) or uracil mustard is a chemotherapy drug which belongs to the class of alkylating agents.[1] It is used in lymphatic malignancies such as non-Hodgkin's lymphoma. It works by damaging DNA, primarily in cancer cells that preferentially take up the uracil due to their need to make nucleic acids during their rapid cycles of cell division. The DNA damage leads to apoptosis of the affected cells. Bone marrow suppression and nausea are the main side effects.

Chemically it is a derivative of nitrogen mustard and uracil.

References[edit]

  1. ^ Ghorani-Azam A, Balali-Mood M (2015). "Clinical pharmacology and toxicology of mustard compounds.". In Balali-Mood M, Abdollahi M (eds.). Basic and clinical toxicology of mustard compounds. Cham: Springer. p. 74. ISBN 978-3-319-23874-6.


  • t
  • e

  • Retrieved from "https://en.wikipedia.org/w/index.php?title=Uramustine&oldid=1147749686"

    Categories: 
    IARC Group 2B carcinogens
    Nitrogen mustards
    Pyrimidinediones
    Organochlorides
    Uracil derivatives
    Chloroethyl compounds
    Antineoplastic and immunomodulating drug stubs
    Hidden categories: 
    Articles with short description
    Short description matches Wikidata
    Articles with changed DrugBank identifier
    Articles with changed ChemSpider identifier
    Articles with changed EBI identifier
    ECHA InfoCard ID from Wikidata
    Articles with changed InChI identifier
    Drugs with no legal status
    Drugboxes which contain changes to verified fields
    Drugboxes which contain changes to watched fields
    All stub articles
     



    This page was last edited on 1 April 2023, at 23:10 (UTC).

    Text is available under the Creative Commons Attribution-ShareAlike License 4.0; additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization.



    Privacy policy

    About Wikipedia

    Disclaimers

    Contact Wikipedia

    Code of Conduct

    Developers

    Statistics

    Cookie statement

    Mobile view



    Wikimedia Foundation
    Powered by MediaWiki